Latest News about LLY
Recent news which mentions LLY
Lilly's COVID-19 Antibody Cocktail Scores FDA Emergency Use For Kids, Including Newborns
December 06, 2021
From Benzinga
Lilly’s COVID-19 antibody drug authorized for use in children
December 03, 2021
Tickers
LLY
Tags
LLY
From MarketWatch
The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering
December 03, 2021
From Benzinga
3 Reasons Pfizer Stock Will Crush the Broader Market in 2022
December 01, 2021
From Motley Fool
From MarketWatch
WHO urges calm approach to omicron variant of COVID, warns travel restrictions may undermine surveillance and tracking
November 30, 2021
From MarketWatch
ADGI Stock Soars as Analysts Lock On to Its Omicron-Fighting Potential
November 29, 2021
From InvestorPlace
From Benzinga
These Biotech Companies Are Attempting to Use Improved Antibody Technology in the Fight To Eradicate COVID-19
November 29, 2021
From Benzinga
Got $5,000? 2 Stocks to Buy and Hold Forever
November 24, 2021
From Motley Fool
Jim Cramer Weighs In On Cano Health, Moderna And More
November 23, 2021
From Benzinga
Is This Pharma Stock a Buy?
November 22, 2021
From Motley Fool
Will Pfizer's COVID Pill Crush the Hopes of Merck Investors?
November 19, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
November 19, 2021
From Benzinga
From MarketWatch
Mobile Mental Health: Coming to a Home Near You?
November 18, 2021
From Benzinga
3 Biotech Stocks That Have More Than Tripled so far This Year
November 18, 2021
From Motley Fool
Jim Cramer Likes This Stock Over Cassava Sciences And Biogen
November 17, 2021
From Benzinga
Could Eli Lilly Leapfrog Biogen in This Market?
November 17, 2021
From Motley Fool
3 Pharma Stocks That Could Make You Richer in November (and Beyond)
November 12, 2021
From Motley Fool
Hit By Slow Rollout, Biogen's Aduhelm Could Soon Find Itself In Price Competition: Reuters
November 10, 2021
From Benzinga
A Deep Dive Into COVID Oral Treatments — What Does the Atea Failure Mean for Oral Antivirals?
November 05, 2021
From Benzinga
A Deep Dive Into COVID Oral Treatments — What Does the Atea Failure Mean for Oral Antivirals?
November 05, 2021
From Benzinga
Why AbCellera Biologics Stock Sank 21.6% in October
November 04, 2021
From Motley Fool
What Investors Should Like About Eli Lilly's Q3 Update
November 04, 2021
From Motley Fool
From Benzinga
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
November 02, 2021
From Benzinga
Down 76%: Is Cortexyme Stock a Bargain?
October 28, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Free News Feed
Get our RSS Feed!
© Copyright 2008 StreetInsider.com
Custom Website Design by Active Media Architects
Custom Website Design by Active Media Architects
